Obstetrics and Gynecology

Koen De Geest, MD

Portrait

Mailing Address

Office: 4626 JCP
Iowa City, IA 52242
Phone: +1 319 356 2015
Email: koen-degeest@uiowa.edu

Education

BS, Basic Sciences, University of Gent, Belgium, 1973
MD, Medicine, University of Gent, Belgium, 1977
Internship, Obstetrics and Gynecology, University of Gent, Belgium, 1978
Residency, Obstetrics and Gynecology, University of Gent, Belgium, 1982
Fellowship, Gynecologic Oncology, Hershey Medical Center, Pennsylvania State University, 1989

Appointments

Primary: Obstetrics & Gynecology

Publications

  • Stone, R, Nick, A, McNeish, I, Balkwill, F, Han, H, Bottsford-Miller, J, Rupairmoole, R, Armaiz-Pena, G, Pecot, C, Coward, J, Deavers, M, Vasquez, H, Urbauer, D, Landen, C, Hu, W, Gershenson, H, Matsuo, K, Shahzad, M, King, E, Tekedereli, I, Ozpolat, B, Ahn, E, Bond, V, Wang, R, Drew, A, Gushiken, F, Lamkin, D, Collins, K, DeGeest, K, Lutgendorf, S, Chiu, W, Lopez-Berestein, G, Afshar-Kharghan, V, Sood, A. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med 366(7):610-8, 2012. [PubMed]
  • Herzog, T, Sill, M, Walker, J, O'Malley, D, Shahin, M, DeGeest, K, Weiner, S, Mutch, D, DeBernardo, R, Lentz, S. A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: a Gynecologic Oncology Group Study (GOG 146Q). Gynecol Oncol 120(3):454-8, 2011. [PubMed]
  • Matei, D, Sill, M, Lankes, H, DeGeest, K, Bristow, R, Mutch, D, Yamada, S, Cohn, D, Calvert, V, Farley, J, Petricoin, E, Birrer, M. Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: a gynecologic oncology group trial. J Clin Oncol 29(1):69-75, 2011. [PubMed]
  • Lutgendorf, S, DeGeest, K, Dahmoush, L, Farley, D, Penedo, F, Bender, D, Goodheart, M, Buekers, T, Mendez, L, Krueger, G, Clevenger, L, Lubaroff, D, Sood, A, Cole, S. Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients. Brain Behav Immun 25(2):250-5, 2011. [PubMed]
  • Nadkarni, N, Rogers, L, Samuelson, M, Neff, T, Bender, D, Ahmed, A, De Geest, K, Button, A, Dupuy, A, Goodheart, M. Zmiz1 is overexpressed in epithelial ovarian cancer and associated with p53 gene mutations. GYNECOLOGIC ONCOLOGY 123(2):446-447, NOV 2011.
  • Girardi, JR, Samuelson, M, Button, A, De Geest, K, Bender, D, Ahmed, A, Goodheart, MJ. The relationship between vascularity, p53 gene mutations and distant metastatic disease in epithelial ovarian carcinoma. GYNECOLOGIC ONCOLOGY 123(2):443-443, NOV 2011.
  • Clements, A, Engle, D, Shelton, D, Neff, T, Park, S, Bender, D, Ahmed, A, De Geest, K, Button, A, Engelhardt, J, Goodheart, M. Lymphoid enhancing factor 1 (Lef-1) overexpression in epithelial ovarian, fallopian tube and peritoneal cancers and associations with clinical factors. GYNECOLOGIC ONCOLOGY 123(2):437-437, NOV 2011.
  • Usha, L, Sill, M, Darcy, K, Benbrook, D, Hurteau, J, Michelin, D, Mannel, R, Hanjani, P, De Geest, K, Godwin, A. A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies. Gynecol Oncol 121(3):455-61, 2011. [PubMed]
  • Monk, B, Sill, M, Hanjani, P, Edwards, R, Rotmensch, J, De Geest, K, Bonebrake, A, Walker, J. Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: a phase II study of the Gynecologic Oncology Group. Gynecol Oncol 120(3):459-63, 2011. [PubMed]
  • Nadkarni, N, Rogers, L, Samuelson, M, Neff, T, Bender, D, Ahmed, A, De Geest, K, Button, A, Dupuy, A, Goodheart, M. Zmiz1 is overexpressed in epithelial ovarian cancer and associated with p53 gene mutations. GYNECOLOGIC ONCOLOGY 123(2):446-447, NOV 2011.